Methylisothiazolinone (MIT)

This is the core MIT issue. Patch-test studies, dermatology reviews, and clinic surveillance consistently identify MIT as a real skin sensitizer that can trigger allergic contact dermatitis, often affecting the hands, face, eyelids, scalp, or other repeatedly exposed areas. That does not mean everyone using an MIT-containing product will react. It does mean MIT deserves more caution than ingredients whose risks are mostly hypothetical.

MIT is one of the better-documented modern examples of a preservative-allergy problem becoming widespread after market use expanded. Reviews and multicenter surveillance describe a sharp rise in patch-test positivity during the 2010s, which is why dermatologists often refer to an MIT allergy epidemic. More recent European and meta-analytic data suggest the prevalence has fallen after tighter regulation, but it has not disappeared.

This is why MIT attracted unusual regulatory attention. European safety reviews concluded that no safe concentration had been adequately demonstrated for leave-on cosmetics, and leave-on exposure - especially wipes - became a well-known source of allergic dermatitis in both adults and children. Rinse-off products appear lower-risk for causing new allergy, but 'lower-risk' is not the same as risk-free, especially once someone is already sensitized.

This is an important nuance. Regulatory opinions focused heavily on induction of new allergy, but for people who already have MIT allergy, even lower-level or rinse-off exposure can still provoke dermatitis. Recent European audit data still linked many clinically relevant reactions to rinse-off cosmetics, and older challenge work suggested some sensitized patients reacted below the former cosmetic maximum. So 'it washes off' is not a reliable reassurance once allergy is established.

MIT is not only a shampoo or lotion issue. Studies and case reports have repeatedly found relevant exposure from household cleaners, detergents, sprays, and paints, including concentrations high enough to matter to sensitized people. That helps explain why some patients keep flaring even after changing personal-care products: the exposure may be coming from the home or workplace instead.

Workers with repeated product contact often have the highest practical risk. Dermatology literature repeatedly flags painters, cleaners, hairdressers, health-care workers, and others with frequent wet work or chemical contact as groups where isothiazolinone exposure can be harder to avoid and easier to miss. That does not make MIT an inevitable occupational hazard in every job. It does mean repeated workplace exposure is a more plausible concern than occasional consumer use in someone with healthy skin and no allergy history.

Stronger online claims about MIT often go well beyond the best human evidence. There are cell, animal, and mechanistic toxicology papers that justify continued scrutiny, but they do not automatically prove that ordinary consumer exposure causes systemic disease, cancer, or neurologic harm in people. Right now the best-established real-world problem is skin allergy. Broad systemic claims should be treated as unproven rather than settled.

This is the LP context claim. MIT is mainly a personal-care, household, and occupational exposure issue rather than a nutrition issue. For most people without allergy, one occasional rinse-off product is unlikely to be the main driver of long-term health. What matters more is the total exposure pattern across wipes, leave-on products, cleaners, detergents, paints, and workplace sources. But if you are already sensitized, one seemingly minor product can still be enough to keep dermatitis going.